Equities

Nyrada Inc

NYR:ASX

Nyrada Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.057
  • Today's Change0.00 / 0.00%
  • Shares traded54.38k
  • 1 Year change+128.00%
  • Beta1.5645
Data delayed at least 20 minutes, as of Sep 19 2024 03:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Nyrada Inc (NYR:ASX) closed at 0.057, 216.67% above the 52 week low of 0.018 set on Feb 20, 2024.
52-week range
Today
0.018Feb 20 20240.17Feb 29 2024
Open0.058
High0.058
Low0.054
Bid0.053
Offer0.056
Previous close0.057
Average volume111.51k
Shares outstanding182.21m
Free float111.04m
P/E (TTM)--
Market cap10.39m AUD
EPS (TTM)-0.0081
AUD
Data delayed at least 20 minutes, as of Sep 19 2024 03:33 BST.
More ▼

Events & Activity

  • NYR:ASX trading volume exceeds daily average by +111.52%
  • NYR:ASX price falls below 200-day moving average to 0.054 at 21:35 BST
  • NYR:ASX price moved over -3.45% to 0.056
  • NYR:ASX price falls below 15-day moving average to 0.054 at 21:35 BST
  • NYR:ASX price falls below 15-day moving average to 0.055 at 23:14 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.